Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Profit After Tax (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Profit After Tax for 3 consecutive years, with -$20.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 29.06% to -$20.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$83.9 million, a 28.29% decrease, with the full-year FY2025 number at -$83.9 million, down 28.29% from a year prior.
  • Profit After Tax was -$20.8 million for Q4 2025 at Artiva Biotherapeutics, up from -$21.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $11.3 million in Q3 2023 to a low of -$21.5 million in Q3 2025.
  • A 3-year average of -$14.7 million and a median of -$17.5 million in 2024 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 254.91% in 2024, then dropped 19.12% in 2025.
  • Artiva Biotherapeutics' Profit After Tax stood at -$12.0 million in 2023, then crashed by 34.15% to -$16.1 million in 2024, then dropped by 29.06% to -$20.8 million in 2025.
  • Per Business Quant, the three most recent readings for ARTV's Profit After Tax are -$20.8 million (Q4 2025), -$21.5 million (Q3 2025), and -$21.3 million (Q2 2025).